Mechanisms, Cofactors, and Augmenting Factors Involved in Anaphylaxis

Anaphylaxis is an acute and life-threatening systemic reaction. Many triggers have been described, including food, drug, and hymenoptera allergens, which are the most frequently involved. The mechanisms described in anaphylactic reactions are complex and implicate a diversity of pathways. Some of th...

Full description

Saved in:
Bibliographic Details
Published inFrontiers in immunology Vol. 8; p. 1193
Main Authors Muñoz-Cano, Rosa, Pascal, Mariona, Araujo, Giovanna, Goikoetxea, M J, Valero, Antonio L, Picado, Cesar, Bartra, Joan
Format Journal Article
LanguageEnglish
Published Switzerland Frontiers Media S.A 26.09.2017
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Anaphylaxis is an acute and life-threatening systemic reaction. Many triggers have been described, including food, drug, and hymenoptera allergens, which are the most frequently involved. The mechanisms described in anaphylactic reactions are complex and implicate a diversity of pathways. Some of these mechanisms may be key to the development of the anaphylactic reaction, while others may only modify its severity. Although specific IgE, mast cells, and basophils are considered the principal players in anaphylaxis, alternative mechanisms have been proposed in non-IgE anaphylactic reactions. Neutrophils, macrophages, as well as basophils, have been involved, as have IgG-dependent, complement and contact system activation. A range of cationic substances can induce antibody-independent mast cells activation through MRGPRX2 receptor. Cofactors and augmenting factors may explain why, in some patients, food allergen exposure can cause anaphylaxis, while in other clinical scenario it can be tolerated or elicits a mild reaction. With the influence of these factors, food allergic reactions may be induced at lower doses of allergen and/or become more severe. Exercise, alcohol, estrogens, and some drugs such as Non-steroidal anti-inflammatory drugs, angiotensin-converting enzyme inhibitors, β-blockers, and lipid-lowering drugs are the main factors described, though their mechanisms and signaling pathways are poorly understood.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Edited by: Carlos Pastor Vargas, Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz, Spain
Specialty section: This article was submitted to Inflammation, a section of the journal Frontiers in Immunology
Reviewed by: Coen Maas, University Medical Center Utrecht, Netherlands; David Dombrowicz, Institut national de la santé et de la recherche médicale, France
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2017.01193